OMNI Study--Assessing Therapies in Medtronic Pacemaker, Defibrillator, and Cardiac Resynchronization Therapy Devices.

NCT ID: NCT00277524

Last Updated: 2013-08-28

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

3032 participants

Study Classification

OBSERVATIONAL

Study Start Date

2005-08-31

Study Completion Date

2010-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the OMNI study is to characterize therapy and diagnostic utilization in study participants implanted with study devices and to describe Implantable Cardioverter Defibrillator(ICD)therapy utilization for life threatening arrhythmias in primary and secondary prevention study participants. This study will assess therapies in Medtronic pacemaker, defibrillator, and cardiac resynchronization therapy devices.

The first therapy is for reducing unnecessary pacing in pacemaker patients. The second therapy provides pacing therapy in an attempt to stop fast or life threatening ventricular arrhythmias in lieu of delivering a defibrillation shock. The third therapy is a diagnostic measurement of a patient's fluid status and provides the physician information on the patient's heart failure status.

The study will also assess the time to a patient's first defibrillation shock and will verify that the shock was for a fast or life threatening ventricular rhythm.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The OMNI results demonstrate the importance of Medtronic's ongoing efforts to increase adoption of evidence based shock-reduction programming strategies. Longer VF NID (number of intervals to detect in the VF zone) should be utilized with the Anti-tachycardia Pacing (ATP) During Charging Feature. ATP during Charging allows physicians to treat with ATP without delay to shock. Therefore, VF NID may be extended to allow episodes the chance to self-terminate immediately to shock by use of the ATP during the charging feature.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tachycardia, Ventricular Heart Failure, Congestive Ventricular Fibrillation Ventricular Dysfunction Bradycardia

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Pacemaker Defibrillator Cardiac Resynchronization Dysynchrony Heart failure Arrhythmia Tachycardia Bradycardia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Overall

All patients enrolled in OMNI. Patient sub-groups include device type, history of atrial fibrillation (AF), history of investigate atrioventricular (AV) block, implant indication, and managed ventricular pacing (MVP) enabled.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Implant of new or replacement study device. Enrollment must occur no later than 40 days post-implant.
* Study participants must be 18 years of age or older.

Exclusion Criteria

* Study participants enrolled or intend to participate in another clinical device trial during the course of this study that required specific treatment or programming.
* Study participants unwilling and unable to comply with follow-up schedule.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medtronic

INDUSTRY

Sponsor Role collaborator

Medtronic Cardiac Rhythm and Heart Failure

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Michael O. Sweeney

Role: PRINCIPAL_INVESTIGATOR

Cardiovascular Division Brigham and Womens

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Southern Arizona Health Care System

Tucson, Arizona, United States

Site Status

Arkansas Cardiology PA (Little Rock AR)

Little Rock, Arkansas, United States

Site Status

California Heart Medical Associates

Fresno, California, United States

Site Status

Apex Cardiology

Inglewood, California, United States

Site Status

Scripps Green Hospital Scripps Clinic Torrey Pines

La Jolla, California, United States

Site Status

Northern California Heart Care

Larkspur, California, United States

Site Status

Mission Internal Medical Group

Mission Viejo, California, United States

Site Status

Orange County Heart Institute & Research Center

Orange, California, United States

Site Status

Foothill Cardiology

Pasadena, California, United States

Site Status

Desert Cardiology Center / Desert Cardiology Medical Group Consultants

Rancho Mirage, California, United States

Site Status

Brett Berman Cardiology & Cardiac Electrophysiology

San Diego, California, United States

Site Status

Dwain L Coggins MD FACC

San Jose, California, United States

Site Status

Cardiology Clinic of San Antonio

Tarzana, California, United States

Site Status

Erol Kosar MD Inc

Torrance, California, United States

Site Status

Rocky Mountain Cardiology PC

Boulder, Colorado, United States

Site Status

Pikes Peak Cardiology

Colorado Springs, Colorado, United States

Site Status

Daytona Heart

Daytona Beach, Florida, United States

Site Status

Florida Arrhythmia Consultants

Fort Lauderdale, Florida, United States

Site Status

Clark & Daughtrey Medical Group PA

Lakeland, Florida, United States

Site Status

Melbourne Internal Medicine Associates / Century Research Associates

Melbourne, Florida, United States

Site Status

C. Raghavan MD PA

Orlando, Florida, United States

Site Status

Northwest Florida Heart Group PA

Pensacola, Florida, United States

Site Status

Heart & Vascular Institute of Florida

Safety Harbor, Florida, United States

Site Status

Florida Cardiovascular Institute PA

Tampa, Florida, United States

Site Status

Interventional Cardiac Consultants PLC

Trinity, Florida, United States

Site Status

Emory University Hospital

Atlanta, Georgia, United States

Site Status

Northeast Georgia Heart Center PC

Gainesville, Georgia, United States

Site Status

Macon Electrophysiology Associates PC

Macon, Georgia, United States

Site Status

Cardiovascular Consultants (Savannah GA)

Savannah, Georgia, United States

Site Status

Edward N Shen MD Inc

Honolulu, Hawaii, United States

Site Status

Midwest Cardiology PC

Belleville, Illinois, United States

Site Status

Cardiovascular Associates

Elk Grove Village, Illinois, United States

Site Status

The Heart Group PC

Evansville, Indiana, United States

Site Status

Saint Mary Medical Center (Community Healthcare System)

Hobart, Indiana, United States

Site Status

Cardiologists PC

Cedar Rapids, Iowa, United States

Site Status

King's Daughters Medical Center

Ashland, Kentucky, United States

Site Status

University Medical Associates

Louisville, Kentucky, United States

Site Status

Cardiovascular Associates LLC

Covington, Louisiana, United States

Site Status

Cardiology Associates PC

Annapolis, Maryland, United States

Site Status

Cardiovascular Specialists of Frederick

Frederick, Maryland, United States

Site Status

The Heart Center

Glen Burnie, Maryland, United States

Site Status

Baltimore Heart Associates (Randallstown MD)

Randallstown, Maryland, United States

Site Status

Shady Grove Adventist Hospital

Rockville, Maryland, United States

Site Status

Peninsula Cardiology Associates

Salisbury, Maryland, United States

Site Status

Internal Medicine & Cardiology Associates of Southeastern New England PC

Fall River, Massachusetts, United States

Site Status

New Bedford Medical Associates

New Bedford, Massachusetts, United States

Site Status

North Shore Cardiology Associates

Salem, Massachusetts, United States

Site Status

University of Massachusetts Memorial Medical Center

Worcester, Massachusetts, United States

Site Status

University of Michigan Health System (UMHS) VA Medical Center

Ann Arbor, Michigan, United States

Site Status

Genesys Regional Medical Center

Grand Blanc, Michigan, United States

Site Status

Borgess Medical Center

Kalamazoo, Michigan, United States

Site Status

Cardiology Consultants of East Michigan

Lapeer, Michigan, United States

Site Status

Great Lakes Heart and Vascular Institute PC

Saint Joseph, Michigan, United States

Site Status

Cardiovascular Clinical Associates PC

Southfield, Michigan, United States

Site Status

University of Minnesota

Minneapolis, Minnesota, United States

Site Status

Mayo Clinic

Rochester, Minnesota, United States

Site Status

Saint Paul Cardiology

Saint Paul, Minnesota, United States

Site Status

Hattiesburg Clinic/Forrest General

Hattiesburg, Mississippi, United States

Site Status

Cardiovascular Consultants (Cape Giradeau MO)

Cape Girardeau, Missouri, United States

Site Status

Cardiology Consultants of Saint Louis County PC

St Louis, Missouri, United States

Site Status

Saint Louis Heart & Vascular PC

St Louis, Missouri, United States

Site Status

Heart Consultants PC

Omaha, Nebraska, United States

Site Status

Reno Heart Physicians

Reno, Nevada, United States

Site Status

New Jersey Heart (Elizabeth NJ)

Elizabeth, New Jersey, United States

Site Status

Englewood Hospital & Medical Center

Englewood, New Jersey, United States

Site Status

Saint Joseph's Regional Medical Center

Paterson, New Jersey, United States

Site Status

Cardiology Associates

Woodland Park, New Jersey, United States

Site Status

Albany Associates in Cardiology

Albany, New York, United States

Site Status

Cardio Research of New York Inc

Bayside, New York, United States

Site Status

New York Medical Center of Queens

New York, New York, United States

Site Status

Heartwise Cardiology

New York, New York, United States

Site Status

Arrhythmia Associates of New York

New York, New York, United States

Site Status

University Cardiovascular Associates (UCVA)

Rochester, New York, United States

Site Status

Cardiology Associates of Schenectady PC

Schenectady, New York, United States

Site Status

Saint Catherine of Sienna Medical Center

Smithtown, New York, United States

Site Status

Sanger Heart and Vascular Institute-Charlotte

Charlotte, North Carolina, United States

Site Status

Heart Rhythm Associates PLLC

Greenville, North Carolina, United States

Site Status

High Point Regional Health System

High Point, North Carolina, United States

Site Status

Wake Heart & Vascular Associates

Raleigh, North Carolina, United States

Site Status

Wilmington Cardiology LLC

Wilmington, North Carolina, United States

Site Status

Forsyth Medical Center

Winston-Salem, North Carolina, United States

Site Status

Altru Hospital

Grand Forks, North Dakota, United States

Site Status

TriHealth Good Samaritan Hos

Cincinnati, Ohio, United States

Site Status

EMH Elyria Medical Center

Elyria, Ohio, United States

Site Status

Heart Care Inc

Gahanna, Ohio, United States

Site Status

Stark Medical Specialties Inc

Massillon, Ohio, United States

Site Status

Ohio Institute of Cardiac Care Inc

Springfield, Ohio, United States

Site Status

The Toledo Clinic

Toledo, Ohio, United States

Site Status

Bluestem Cardiology PC

Bartlesville, Oklahoma, United States

Site Status

Heart Consultants

Midwest City, Oklahoma, United States

Site Status

Terrance Khastgir MD PC

Oklahoma City, Oklahoma, United States

Site Status

Pacific Heart Associates

Portland, Oregon, United States

Site Status

Altoona Regional Health Center

Altoona, Pennsylvania, United States

Site Status

Arrhythmia Institute

Newtown, Pennsylvania, United States

Site Status

Cardiology Consultants of Philadelphia

Philadelphia, Pennsylvania, United States

Site Status

Marshall-Rismiller & Associates

Pottsville, Pennsylvania, United States

Site Status

Columbia Heart Clinic PA

Columbia, South Carolina, United States

Site Status

Pee Dee Cardiology

Florence, South Carolina, United States

Site Status

Piedmont Cardiology Associates (Greenwood SC)

Greenwood, South Carolina, United States

Site Status

Memphis Heart Clinic

Memphis, Tennessee, United States

Site Status

James H Quillen VA Medical Center

Mountain Home, Tennessee, United States

Site Status

Amarillo Heart Group

Amarillo, Texas, United States

Site Status

Dallas VA Medical Center

Dallas, Texas, United States

Site Status

Hall Garcia Cardiology Associates

Houston, Texas, United States

Site Status

Heart Clinic PLLC

McAllen, Texas, United States

Site Status

Medical Center Hospital Odessa

Odessa, Texas, United States

Site Status

Cardiology Clinic of San Antonio

San Antonio, Texas, United States

Site Status

Cardiovascular Associates of East Texas PA

Tyler, Texas, United States

Site Status

Utah Cardiology (Ogden UT)

Ogden, Utah, United States

Site Status

Virginia Cardiovascular Specialists PC

Richmond, Virginia, United States

Site Status

CAMC Institute Clinical Trials Center

Charleston, West Virginia, United States

Site Status

Wisconsin Heart SC

Madison, Wisconsin, United States

Site Status

Arrhythmia Consultants of Milwaukee SC

Wauwatosa, Wisconsin, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO, Canby RC, Khalighi K, Machado C, Rubenstein DS, Volosin KJ; PainFREE Rx II Investigators. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation. 2004 Oct 26;110(17):2591-6. doi: 10.1161/01.CIR.0000145610.64014.E4. Epub 2004 Oct 18.

Reference Type BACKGROUND
PMID: 15492306 (View on PubMed)

Alpert JS. Are data from clinical registries of any value? Eur Heart J. 2000 Sep;21(17):1399-401. doi: 10.1053/euhj.2000.2265. No abstract available.

Reference Type BACKGROUND
PMID: 10952831 (View on PubMed)

Lamas GA, Williams A. Have the results of randomized clinical trials of pacing altered the practice of cardiac pacing? J Cardiovasc Electrophysiol. 2003 Sep;14(9 Suppl):S15-9. doi: 10.1046/j.1540-8167.14.s9.14.x.

Reference Type BACKGROUND
PMID: 12950512 (View on PubMed)

Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005 Jan 20;352(3):225-37. doi: 10.1056/NEJMoa043399.

Reference Type BACKGROUND
PMID: 15659722 (View on PubMed)

Liang KY, Zeger S. Longitudinal data analysis using generalized linear models. Biometrika, 1986, 73:13-22.

Reference Type BACKGROUND

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

601

Identifier Type: -

Identifier Source: org_study_id